Skip to main content
Top
Published in: Rheumatology International 7/2007

01-05-2007 | Original Article

Evaluation of quality of life using ASQoL questionnaire in patients with ankylosing spondylitis in a Chinese population

Authors: L. K. Zhao, Z. T. Liao, C. H. Li, T. W. Li, J. Wu, Q. Lin, F. Huang, D. T. Yu, J. R. Gu

Published in: Rheumatology International | Issue 7/2007

Login to get access

Abstract

The purpose of this study was to evaluate the reliability of Chinese version of the ankylosing spondylitis quality of life questionnaire (ASQoL) for AS patients. All the enrolled AS patients should fulfill five questionnaires (BASDAI, BASFI, DFI, BAS-G and ASQoL) by himself, then the investigators did physical examination of the patients, fulfilling BASMI. Physical function has a strong correlation with QoL in patients with AS. In different disease activity groups, ASQoL had a correlation with BASFI, especially in the moderate activity group (γ = 0.66, P < 0.0001). All four questionnaires in entanacept treatment group improved distinctly on week 6 and 12 comparing to baseline. There were significantly correlations of changing between ASQoL and BAS-G, BASDAI and BASFI after treatment with etanercept in AS patients. The Chinese ASQoL questionnaire is valuable to evaluate the activity of AS patients and effect of biologic agent treatment in patients with AS. It is a good generic instrument to measure QoL in patients with AS in China.
Literature
1.
go back to reference Chamberlain MA (1983) Soci-economic effects of ankylosing spondylitis in females: a comparison of 25 female with 25 male subjects. Int Rehabil Med 5:149–153PubMed Chamberlain MA (1983) Soci-economic effects of ankylosing spondylitis in females: a comparison of 25 female with 25 male subjects. Int Rehabil Med 5:149–153PubMed
2.
go back to reference Dougados M, Gueugen A, Nakache JP et al (1988) Evaluation of the functional index and an articular index in ankylosing spondylitis. J Rheumatol 15:302–307PubMed Dougados M, Gueugen A, Nakache JP et al (1988) Evaluation of the functional index and an articular index in ankylosing spondylitis. J Rheumatol 15:302–307PubMed
3.
go back to reference Daltroy LH, Larson MG, Liang MH (1990) A modification of the health assessment questionnaire for the spondyloarthropathies. J Rheumatic 17:946–950 Daltroy LH, Larson MG, Liang MH (1990) A modification of the health assessment questionnaire for the spondyloarthropathies. J Rheumatic 17:946–950
4.
go back to reference Guillemin F, Challier B, Uriacher F et al (1999) Quality of life in ankylosing spondylitis: validation of the ankylosing spondylitis arthritis impact measurement scales2, a modified arthritis impact measurement scales questionnaire. Arthritis Care Res 12:157–162PubMedCrossRef Guillemin F, Challier B, Uriacher F et al (1999) Quality of life in ankylosing spondylitis: validation of the ankylosing spondylitis arthritis impact measurement scales2, a modified arthritis impact measurement scales questionnaire. Arthritis Care Res 12:157–162PubMedCrossRef
5.
go back to reference Doward LC, Spoorenberg A, Cook SA et al (2003) Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 62:20–26PubMedCrossRef Doward LC, Spoorenberg A, Cook SA et al (2003) Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 62:20–26PubMedCrossRef
6.
go back to reference Van der Linden S,Valkenburg HA et al (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMedCrossRef Van der Linden S,Valkenburg HA et al (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMedCrossRef
7.
go back to reference Garrett S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). J Rheumatic 21:2286–2291 Garrett S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). J Rheumatic 21:2286–2291
8.
go back to reference Borman P, Bodur H, Bingol N et al (2001) Bone mineral density and bone turnover markers in a group of male ankylosing spondylitis: relationship to disease activity. J Clin Rheumatic 7:315–321CrossRef Borman P, Bodur H, Bingol N et al (2001) Bone mineral density and bone turnover markers in a group of male ankylosing spondylitis: relationship to disease activity. J Clin Rheumatic 7:315–321CrossRef
9.
go back to reference Spoorenberg A, van der Heijde D, Klerk E et al (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:980–984PubMed Spoorenberg A, van der Heijde D, Klerk E et al (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:980–984PubMed
10.
go back to reference Jenkinson TR, Mallorie PA, Whitelock HC et al (1994) Defining spinal mobility in ankylosing spondylitis (AS): the Bath AS Metrology Index. J Rheumatic 21:1694–698 Jenkinson TR, Mallorie PA, Whitelock HC et al (1994) Defining spinal mobility in ankylosing spondylitis (AS): the Bath AS Metrology Index. J Rheumatic 21:1694–698
11.
go back to reference Calin A, S Garrett et al (1994) A new approach defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Guncrional Index. J Rheumatol 21:2281–2285PubMed Calin A, S Garrett et al (1994) A new approach defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Guncrional Index. J Rheumatol 21:2281–2285PubMed
12.
go back to reference Barlow JH, Macey SJ, Struthers GR et al (1993) Gender, depression, and ankylosing spondylitis. Arthritis Care Res 6:45–51PubMedCrossRef Barlow JH, Macey SJ, Struthers GR et al (1993) Gender, depression, and ankylosing spondylitis. Arthritis Care Res 6:45–51PubMedCrossRef
13.
go back to reference Ariza-Ariza R, Hernandez-Cruz B, Navarro-Sarabia F (2003) Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis. Arthritis Rheum 49:483–487PubMedCrossRef Ariza-Ariza R, Hernandez-Cruz B, Navarro-Sarabia F (2003) Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis. Arthritis Rheum 49:483–487PubMedCrossRef
14.
go back to reference Challier B, Urlacher F, Vancon G et al (1999) Is quality of life affected by season and weather conditions in ankylosing spondylitis? Clin Exp Theumatol 12:247–255 Challier B, Urlacher F, Vancon G et al (1999) Is quality of life affected by season and weather conditions in ankylosing spondylitis? Clin Exp Theumatol 12:247–255
15.
go back to reference Ward MM (1998) Quality of life in patients with ankylosing spondylitis. Rheum Dis Clin North Am 24:815–824PubMedCrossRef Ward MM (1998) Quality of life in patients with ankylosing spondylitis. Rheum Dis Clin North Am 24:815–824PubMedCrossRef
16.
go back to reference Ward MM (1999) Health-related quality of life in ankylosing spondylitis: a survey of 175 patients. Arthritis Care Res 12:247–255PubMedCrossRef Ward MM (1999) Health-related quality of life in ankylosing spondylitis: a survey of 175 patients. Arthritis Care Res 12:247–255PubMedCrossRef
17.
go back to reference Bostan EE, Borman P, Bodur H (2003) Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int 23:121–6PubMed Bostan EE, Borman P, Bodur H (2003) Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int 23:121–6PubMed
18.
go back to reference Heuft-Dorenbosch L, van Tubergen A, Spoorenberg A et al (2004) The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. Arthritis Rheum 51:154–159PubMedCrossRef Heuft-Dorenbosch L, van Tubergen A, Spoorenberg A et al (2004) The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. Arthritis Rheum 51:154–159PubMedCrossRef
19.
go back to reference Ruof J, Stucki G (1999) Balidity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol 26:966–970PubMed Ruof J, Stucki G (1999) Balidity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol 26:966–970PubMed
20.
go back to reference Marzo-Ortega H, McGonagle D, O’Connor P, Emery P (2001) Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study. Arthritis Rheum 44:2112–2117PubMedCrossRef Marzo-Ortega H, McGonagle D, O’Connor P, Emery P (2001) Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study. Arthritis Rheum 44:2112–2117PubMedCrossRef
21.
go back to reference Tan AL, Marzo-Ortega H, O’Connor P, Fraser A, Emery P, McGonagle D (2004) Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study. Ann Rheum Dis 63:1041–1045PubMedCrossRef Tan AL, Marzo-Ortega H, O’Connor P, Fraser A, Emery P, McGonagle D (2004) Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study. Ann Rheum Dis 63:1041–1045PubMedCrossRef
Metadata
Title
Evaluation of quality of life using ASQoL questionnaire in patients with ankylosing spondylitis in a Chinese population
Authors
L. K. Zhao
Z. T. Liao
C. H. Li
T. W. Li
J. Wu
Q. Lin
F. Huang
D. T. Yu
J. R. Gu
Publication date
01-05-2007
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 7/2007
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-006-0267-4

Other articles of this Issue 7/2007

Rheumatology International 7/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.